What is Perry Baromedical?
Perry Baromedical is a distinguished leader in the manufacturing, installation, and servicing of hyperbaric oxygen therapy (HBOT) systems. With over five decades of operational experience, the company has established a robust reputation for delivering high-quality HBOT solutions. Their product portfolio encompasses a wide array of chambers, including monoplace, dualplace, and multiplace configurations, complemented by essential accessories and equipment. Perry Baromedical also extends its expertise to facility design, preventative maintenance programs, and specialized training for medical professionals, catering to healthcare facilities and practitioners seeking advanced hyperbaric solutions.
How much funding has Perry Baromedical raised?
Perry Baromedical has raised a total of $520K across 2 funding rounds:
Debt
$150K
Debt
$370K
Debt (2020): $150K with participation from PPP
Debt (2021): $370K led by PPP
Key Investors in Perry Baromedical
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Perry Baromedical?
The recent major strategic investment signals a pivotal phase for Perry Baromedical, likely aimed at accelerating product development, expanding market reach, or enhancing operational capabilities. Given the enterprise-level context of its total funding, the company appears poised for significant scaling. Future initiatives may involve further innovation in HBOT technology, strategic partnerships to broaden its service offerings, or expansion into new geographical markets. This capital infusion is expected to fortify its position as a key provider in the medical device industry, particularly within the specialized field of hyperbaric medicine.
See full Perry Baromedical company page
